Schedule 13G ownership disclosure
AN2 Therapeutics, Inc.
Security class unavailable · CUSIP: 037326105
Event date: 2023-06-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,000,076
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-23-000083
- Form type
- SC 13G
- Filer
- AN2 Therapeutics, Inc.
- CIK
- CIK 1880438
- Filed
- Jul 05, 2023
- Reporting period
- Jun 26, 2023
- Description
- Schedule 13G beneficial ownership